243 related articles for article (PubMed ID: 8642349)
1. Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin.
Uguccioni M; Loetscher P; Forssmann U; Dewald B; Li H; Lima SH; Li Y; Kreider B; Garotta G; Thelen M; Baggiolini M
J Exp Med; 1996 May; 183(5):2379-84. PubMed ID: 8642349
[TBL] [Abstract][Full Text] [Related]
2. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils.
Ponath PD; Qin S; Post TW; Wang J; Wu L; Gerard NP; Newman W; Gerard C; Mackay CR
J Exp Med; 1996 Jun; 183(6):2437-48. PubMed ID: 8676064
[TBL] [Abstract][Full Text] [Related]
3. Delayed production of biologically active O-glycosylated forms of human eotaxin by tumor-necrosis-factor-alpha-stimulated dermal fibroblasts.
Noso N; Bartels J; Mallet AI; Mochizuki M; Christophers E; Schröder JM
Eur J Biochem; 1998 Apr; 253(1):114-22. PubMed ID: 9578468
[TBL] [Abstract][Full Text] [Related]
4. Cloning, expression, and characterization of the human eosinophil eotaxin receptor.
Daugherty BL; Siciliano SJ; DeMartino JA; Malkowitz L; Sirotina A; Springer MS
J Exp Med; 1996 May; 183(5):2349-54. PubMed ID: 8642344
[TBL] [Abstract][Full Text] [Related]
5. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils.
White JR; Imburgia C; Dul E; Appelbaum E; O'Donnell K; O'Shannessy DJ; Brawner M; Fornwald J; Adamou J; Elshourbagy NA; Kaiser K; Foley JJ; Schmidt DB; Johanson K; Macphee C; Moores K; McNulty D; Scott GF; Schleimer RP; Sarau HM
J Leukoc Biol; 1997 Nov; 62(5):667-75. PubMed ID: 9365122
[TBL] [Abstract][Full Text] [Related]
6. Human RANTES acts as a receptor antagonist for guinea pig eotaxin in vitro and in vivo.
Marleau S; Griffiths-Johnson DA; Collins PD; Bakhle YS; Williams TJ; Jose PJ
J Immunol; 1996 Nov; 157(9):4141-6. PubMed ID: 8892650
[TBL] [Abstract][Full Text] [Related]
7. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils.
Ponath PD; Qin S; Ringler DJ; Clark-Lewis I; Wang J; Kassam N; Smith H; Shi X; Gonzalo JA; Newman W; Gutierrez-Ramos JC; Mackay CR
J Clin Invest; 1996 Feb; 97(3):604-12. PubMed ID: 8609214
[TBL] [Abstract][Full Text] [Related]
8. Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines.
Stellato C; Collins P; Ponath PD; Soler D; Newman W; La Rosa G; Li H; White J; Schwiebert LM; Bickel C; Liu M; Bochner BS; Williams T; Schleimer RP
J Clin Invest; 1997 Mar; 99(5):926-36. PubMed ID: 9062350
[TBL] [Abstract][Full Text] [Related]
9. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines.
Uguccioni M; Mackay CR; Ochensberger B; Loetscher P; Rhis S; LaRosa GJ; Rao P; Ponath PD; Baggiolini M; Dahinden CA
J Clin Invest; 1997 Sep; 100(5):1137-43. PubMed ID: 9276730
[TBL] [Abstract][Full Text] [Related]
10. Monocyte chemoattractant protein-3 is a functional ligand for CC chemokine receptors 1 and 2B.
Combadiere C; Ahuja SK; Van Damme J; Tiffany HL; Gao JL; Murphy PM
J Biol Chem; 1995 Dec; 270(50):29671-5. PubMed ID: 8530354
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3.
Kitaura M; Nakajima T; Imai T; Harada S; Combadiere C; Tiffany HL; Murphy PM; Yoshie O
J Biol Chem; 1996 Mar; 271(13):7725-30. PubMed ID: 8631813
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the structure of vMIP-II with eotaxin-1, RANTES, and MCP-3 suggests a unique mechanism for CCR3 activation.
Fernandez EJ; Wilken J; Thompson DA; Peiper SC; Lolis E
Biochemistry; 2000 Oct; 39(42):12837-44. PubMed ID: 11041848
[TBL] [Abstract][Full Text] [Related]
13. Murine monocyte chemoattractant protein (MCP)-5: a novel CC chemokine that is a structural and functional homologue of human MCP-1.
Sarafi MN; Garcia-Zepeda EA; MacLean JA; Charo IF; Luster AD
J Exp Med; 1997 Jan; 185(1):99-109. PubMed ID: 8996246
[TBL] [Abstract][Full Text] [Related]
14. Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2(6-76) as a natural chemokine inhibitor.
Proost P; Struyf S; Couvreur M; Lenaerts JP; Conings R; Menten P; Verhaert P; Wuyts A; Van Damme J
J Immunol; 1998 Apr; 160(8):4034-41. PubMed ID: 9558113
[TBL] [Abstract][Full Text] [Related]
15. Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV.
Van Coillie E; Proost P; Van Aelst I; Struyf S; Polfliet M; De Meester I; Harvey DJ; Van Damme J; Opdenakker G
Biochemistry; 1998 Sep; 37(36):12672-80. PubMed ID: 9730840
[TBL] [Abstract][Full Text] [Related]
16. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3.
Garcia-Zepeda EA; Combadiere C; Rothenberg ME; Sarafi MN; Lavigne F; Hamid Q; Murphy PM; Luster AD
J Immunol; 1996 Dec; 157(12):5613-26. PubMed ID: 8955214
[TBL] [Abstract][Full Text] [Related]
17. C-C chemokines, but not the C-X-C chemokines interleukin-8 and interferon-gamma inducible protein-10, stimulate transendothelial chemotaxis of T lymphocytes.
Roth SJ; Carr MW; Springer TA
Eur J Immunol; 1995 Dec; 25(12):3482-8. PubMed ID: 8566041
[TBL] [Abstract][Full Text] [Related]
18. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes.
Forssmann U; Uguccioni M; Loetscher P; Dahinden CA; Langen H; Thelen M; Baggiolini M
J Exp Med; 1997 Jun; 185(12):2171-6. PubMed ID: 9182688
[TBL] [Abstract][Full Text] [Related]
19. Eotaxin and monocyte chemotactic protein-3 use different modes of action.
Chung IY; Kim YH; Choi MK; Noh YJ; Park CS; Kwon DY; Lee DY; Lee YS; Chang HS; Kim KS
Biochem Biophys Res Commun; 2004 Feb; 314(2):646-53. PubMed ID: 14733956
[TBL] [Abstract][Full Text] [Related]
20. Monocyte chemotactic proteins MCP-1, MCP-2, and MCP-3 are major attractants for human CD4+ and CD8+ T lymphocytes.
Loetscher P; Seitz M; Clark-Lewis I; Baggiolini M; Moser B
FASEB J; 1994 Oct; 8(13):1055-60. PubMed ID: 7926371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
